LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 53

Search options

  1. Article: Comment on: Zika virus and Guillain-Barré syndrome in Bangladesh.

    Rodríguez, Yhojan / Anaya, Juan-Manuel

    Annals of clinical and translational neurology

    2018  Volume 5, Issue 9, Page(s) 1139

    Language English
    Publishing date 2018-07-13
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2740696-9
    ISSN 2328-9503
    ISSN 2328-9503
    DOI 10.1002/acn3.602
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Metabolic fingerprinting of systemic sclerosis: a systematic review.

    Morales-González, Victoria / Galeano-Sánchez, Daniel / Covaleda-Vargas, Jaime Enrique / Rodriguez, Yhojan / Monsalve, Diana M / Pardo-Rodriguez, Daniel / Cala, Mónica P / Acosta-Ampudia, Yeny / Ramírez-Santana, Carolina

    Frontiers in molecular biosciences

    2023  Volume 10, Page(s) 1215039

    Abstract: Introduction: ...

    Abstract Introduction:
    Language English
    Publishing date 2023-08-08
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2814330-9
    ISSN 2296-889X
    ISSN 2296-889X
    DOI 10.3389/fmolb.2023.1215039
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Cholangiopathy as part of post-COVID syndrome.

    Rojas, Manuel / Rodríguez, Yhojan / Zapata, Elizabeth / Hernández, Juan Carlos / Anaya, Juan-Manuel

    Journal of translational autoimmunity

    2021  Volume 4, Page(s) 100116

    Abstract: Liver compromise in critically ill patients with coronavirus disease 2019 (COVID-19) is common but usually transient and self-limited. However, liver tests on some patients continue to show abnormal results. Herein, a 29-year-old patient with clinical ... ...

    Abstract Liver compromise in critically ill patients with coronavirus disease 2019 (COVID-19) is common but usually transient and self-limited. However, liver tests on some patients continue to show abnormal results. Herein, a 29-year-old patient with clinical and histological features of cholangiopathy is presented. Despite treatment with ursodeoxycholic acid and cholestyramine, bilirubin and transaminase levels remained elevated. This case report raises awareness of the difficulty of managing this condition in patients with COVID-19.
    Language English
    Publishing date 2021-08-31
    Publishing country Netherlands
    Document type Case Reports
    ISSN 2589-9090
    ISSN (online) 2589-9090
    DOI 10.1016/j.jtauto.2021.100116
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Comment on: Nature and Dimensions of the Systemic Hyper-inflammation and Its Attenuation by Convalescent Plasma in Severe COVID-19.

    Acosta-Ampudia, Yeny / Rojas, Manuel / Monsalve, Diana M / Rodríguez, Yhojan / Ramírez-Santana, Carolina / Anaya, Juan-Manuel

    The Journal of infectious diseases

    2021  Volume 223, Issue 10, Page(s) 1833–1834

    Language English
    Publishing date 2021-03-10
    Publishing country United States
    Document type Journal Article ; Comment
    ZDB-ID 3019-3
    ISSN 1537-6613 ; 0022-1899
    ISSN (online) 1537-6613
    ISSN 0022-1899
    DOI 10.1093/infdis/jiab137
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: COVID-19 vaccine and autoimmunity. A new case of autoimmune hepatitis and review of the literature.

    Camacho-Domínguez, Laura / Rodríguez, Yhojan / Polo, Fernando / Restrepo Gutierrez, Juan Carlos / Zapata, Elizabeth / Rojas, Manuel / Anaya, Juan-Manuel

    Journal of translational autoimmunity

    2022  Volume 5, Page(s) 100140

    Abstract: Autoimmunity following COVID-19 vaccination has been reported. Herein, a 79-year-old man with clinical and immunological features of autoimmune hepatitis type 1 after ChAdOx1 nCoV-19 vaccination is presented. Clinical manifestations rapidly remitted ... ...

    Abstract Autoimmunity following COVID-19 vaccination has been reported. Herein, a 79-year-old man with clinical and immunological features of autoimmune hepatitis type 1 after ChAdOx1 nCoV-19 vaccination is presented. Clinical manifestations rapidly remitted after the instauration of immunomodulatory management. This case, together with a comprehensive review of the literature, illustrates the association between COVID-19 vaccines and the development of autoimmune conditions.
    Language English
    Publishing date 2022-01-04
    Publishing country Netherlands
    Document type Case Reports
    ISSN 2589-9090
    ISSN (online) 2589-9090
    DOI 10.1016/j.jtauto.2022.100140
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Persistent Autoimmune Activation and Proinflammatory State in Post-Coronavirus Disease 2019 Syndrome.

    Acosta-Ampudia, Yeny / Monsalve, Diana M / Rojas, Manuel / Rodríguez, Yhojan / Zapata, Elizabeth / Ramírez-Santana, Carolina / Anaya, Juan-Manuel

    The Journal of infectious diseases

    2022  Volume 225, Issue 12, Page(s) 2155–2162

    Abstract: Background: The immunopathological pathways enabling post-coronavirus disease 2019 (COVID-19) syndrome (PCS) development are not entirely known. We underwent a longitudinal analysis of patients with COVID-19 who developed PCS aiming to evaluate the ... ...

    Abstract Background: The immunopathological pathways enabling post-coronavirus disease 2019 (COVID-19) syndrome (PCS) development are not entirely known. We underwent a longitudinal analysis of patients with COVID-19 who developed PCS aiming to evaluate the autoimmune and immunological status associated with this condition.
    Methods: Thirty-three patients were included for longitudinal clinical and autoantibody analyses, 12 of whom were assessed for cytokines and lymphocyte populations. Patients were followed for 7-11 months after acute COVID-19. Autoimmune profile and immunological statuses were evaluated mainly by enzyme-linked-immunosorbent assays and flow cytometry.
    Results: Latent autoimmunity and overt autoimmunity persisted over time. A proinflammatory state was observed in patients with PCS characterized by up-regulated interferon-α, tumor necrosis factor-α, granulocyte colony-stimulating factor (G-CSF), interleukin (IL)-17A, IL-6, IL-1β, and IL-13, whereas interferon-γ-induced protein 10 (IP-10) was decreased. In addition, PCS was characterized by increased levels of Th9, CD8+ effector T cells, naive B cells, and CD4+ effector memory T cells. Total levels of immunoglobulin G S1-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies remained elevated over time.
    Conclusions: The clinical manifestations of PCS are associated with the persistence of a proinflammatory and effector phenotype induced by SARS-CoV-2 infection. This long-term persistent immune activation may contribute to the development of latent and overt autoimmunity. Results suggest the need to evaluate the role of immunomodulation in the treatment of PCS.
    MeSH term(s) Autoimmunity ; COVID-19/complications ; Cytokines ; Humans ; Inflammation ; Interferon-gamma ; SARS-CoV-2
    Chemical Substances Cytokines ; Interferon-gamma (82115-62-6)
    Language English
    Publishing date 2022-01-21
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 3019-3
    ISSN 1537-6613 ; 0022-1899
    ISSN (online) 1537-6613
    ISSN 0022-1899
    DOI 10.1093/infdis/jiac017
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Autoimmunity is a hallmark of post-COVID syndrome.

    Rojas, Manuel / Rodríguez, Yhojan / Acosta-Ampudia, Yeny / Monsalve, Diana M / Zhu, Chengsong / Li, Quan-Zhen / Ramírez-Santana, Carolina / Anaya, Juan-Manuel

    Journal of translational medicine

    2022  Volume 20, Issue 1, Page(s) 129

    Abstract: Autoimmunity has emerged as a characteristic of the post-COVID syndrome (PCS), which may be related to sex. In order to further investigate the relationship between SARS-CoV-2 and autoimmunity in PCS, a clinical and serological assessment on 100 patients ...

    Abstract Autoimmunity has emerged as a characteristic of the post-COVID syndrome (PCS), which may be related to sex. In order to further investigate the relationship between SARS-CoV-2 and autoimmunity in PCS, a clinical and serological assessment on 100 patients was done. Serum antibody profiles against self-antigens and infectious agents were evaluated by an antigen array chip for 116 IgG and 104 IgM antibodies. Thirty pre-pandemic healthy individuals were included as a control group. The median age of patients was 49 years (IQR: 37.8 to 55.3). There were 47 males. The median post-COVID time was 219 (IQR: 143 to 258) days. Latent autoimmunity and polyautoimmunity were found in 83% and 62% of patients, respectively. Three patients developed an overt autoimmune disease. IgG antibodies against IL-2, CD8B, and thyroglobulin were found in more than 10% of the patients. Other IgG autoantibodies, such as anti-interferons, were positive in 5-10% of patients. Anti-SARS-CoV-2 IgG antibodies were found in > 85% of patients and were positively correlated with autoantibodies, age, and body mass index (BMI). Few autoantibodies were influenced by age and BMI. There was no effect of gender on the over- or under-expression of autoantibodies. IgG anti-IFN-λ antibodies were associated with the persistence of respiratory symptoms. In summary, autoimmunity is characteristic of PCS, and latent autoimmunity correlates with humoral response to SARS-CoV-2.
    MeSH term(s) Adult ; Antibodies, Viral/blood ; Autoimmunity ; COVID-19 ; Humans ; Immunoglobulin M/blood ; Male ; Middle Aged ; SARS-CoV-2
    Chemical Substances Antibodies, Viral ; Immunoglobulin M
    Language English
    Publishing date 2022-03-16
    Publishing country England
    Document type Letter ; Research Support, Non-U.S. Gov't ; Comment
    ZDB-ID 2118570-0
    ISSN 1479-5876 ; 1479-5876
    ISSN (online) 1479-5876
    ISSN 1479-5876
    DOI 10.1186/s12967-022-03328-4
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Autoimmune and autoinflammatory conditions after COVID-19 vaccination. New case reports and updated literature review.

    Rodríguez, Yhojan / Rojas, Manuel / Beltrán, Santiago / Polo, Fernando / Camacho-Domínguez, Laura / Morales, Samuel David / Gershwin, M Eric / Anaya, Juan-Manuel

    Journal of autoimmunity

    2022  Volume 132, Page(s) 102898

    Abstract: Autoimmunity linked to COVID-19 immunization has been recorded throughout the pandemic. Herein we present six new patients who experienced relapses of previous autoimmune disease (AD) or developed a new autoimmune or autoinflammatory condition following ... ...

    Abstract Autoimmunity linked to COVID-19 immunization has been recorded throughout the pandemic. Herein we present six new patients who experienced relapses of previous autoimmune disease (AD) or developed a new autoimmune or autoinflammatory condition following vaccination. In addition, we documented additional cases through a systematic review of the literature up to August 1st, 2022, in which 464 studies (928 cases) were included. The majority of patients (53.6%) were women, with a median age of 48 years (IQR: 34 to 66). The median period between immunization and the start of symptoms was eight days (IQR: 3 to 14). New-onset conditions were observed in 81.5% (n: 756) of the cases. The most common diseases associated with new-onset events following vaccination were immune thrombocytopenia, myocarditis, and Guillain-Barré syndrome. In contrast, immune thrombocytopenia, psoriasis, IgA nephropathy, and systemic lupus erythematosus were the most common illnesses associated with relapsing episodes (18.5%, n: 172). The first dosage was linked with new-onset events (69.8% vs. 59.3%, P = 0.0100), whereas the second dose was related to relapsing disease (29.5% vs. 59.3%, P = 0.0159). New-onset conditions and relapsing diseases were more common in women (51.5% and 62.9%, respectively; P = 0.0081). The groups were evenly balanced in age. No deaths were recorded after the disease relapsed, while 4.7% of patients with new-onset conditions died (P = 0.0013). In conclusion, there may be an association between COVID-19 vaccination and autoimmune and inflammatory diseases. Some ADs seem to be more common than others. Vaccines and SARS-CoV-2 may induce autoimmunity through similar mechanisms. Large, well-controlled studies are warranted to validate this relationship and assess additional variables such as genetic and other environmental factors.
    MeSH term(s) Adult ; Aged ; Female ; Humans ; Male ; Middle Aged ; COVID-19/epidemiology ; COVID-19/prevention & control ; COVID-19 Vaccines/adverse effects ; Immune System Diseases ; Purpura, Thrombocytopenic, Idiopathic/epidemiology ; Purpura, Thrombocytopenic, Idiopathic/etiology ; SARS-CoV-2 ; Thrombocytopenia ; Vaccination/adverse effects
    Chemical Substances COVID-19 Vaccines
    Language English
    Publishing date 2022-08-24
    Publishing country England
    Document type Case Reports ; Journal Article ; Review ; Research Support, Non-U.S. Gov't
    ZDB-ID 639452-8
    ISSN 1095-9157 ; 0896-8411
    ISSN (online) 1095-9157
    ISSN 0896-8411
    DOI 10.1016/j.jaut.2022.102898
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Osteoarticular manifestations of Mayaro virus infection.

    Arenívar, Carlos / Rodríguez, Yhojan / Rodríguez-Morales, Alfonso J / Anaya, Juan-Manuel

    Current opinion in rheumatology

    2019  Volume 31, Issue 5, Page(s) 512–516

    Abstract: Purpose of review: To carry out an update on the state of the art of the Mayaro virus (MAYV) infection and its osteoarticular implications.: Recent findings: There is a wide distribution of MAYV in Latin America and documented exported cases to the ... ...

    Abstract Purpose of review: To carry out an update on the state of the art of the Mayaro virus (MAYV) infection and its osteoarticular implications.
    Recent findings: There is a wide distribution of MAYV in Latin America and documented exported cases to the United States and Europe. Although osteoarticular involvement is not the most frequent, it is one the most associated with disability. The main mechanisms related to arthropathy involves cellular infiltrates (i.e. macrophages, natural killer cells, lymphocytes) together with production of cytokines, such as IL-6, IL-7, IL8, IL-12p70.
    Summary: MAYV infection is an emerging disease, which has been reported in many and increasing number of countries of Latin America. There is a high risk of epidemic outbreaks, given the inadequate vector control (Aedes mosquitoes). Its main symptoms, like other arbovirus infections, involve the presence of headache, rash, conjunctivitis, and arthralgias. MAYV arthropathy is usually severe, can last in time, and is associated with severe disability. There is currently no treatment for MAYV. Prevention of MAYV as a public health burden will be achieved by integrating vector control with vaccines (still under development).
    MeSH term(s) Alphavirus/immunology ; Alphavirus Infections/complications ; Antibodies, Viral/immunology ; Autoimmunity ; Humans ; Joint Diseases/etiology ; Joint Diseases/immunology ; Joint Diseases/virology
    Chemical Substances Antibodies, Viral
    Language English
    Publishing date 2019-08-15
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 1045317-9
    ISSN 1531-6963 ; 1040-8711
    ISSN (online) 1531-6963
    ISSN 1040-8711
    DOI 10.1097/BOR.0000000000000635
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article: Impact of hyperprolactinemia in a patient with polyautoimmunity.

    Rojas, Manuel / Rodríguez, Yhojan / Ramírez-Santana, Carolina / Anaya, Juan-Manuel

    Clinical case reports

    2018  Volume 7, Issue 1, Page(s) 19–23

    Abstract: Hyperprolactinemia has been proposed as a triggering factor for autoimmune diseases. The increased levels of prolactin could induce an abnormal immune response. Herein, we present a patient with hyperprolactinemia who developed polyautoimmunity. Patient' ... ...

    Abstract Hyperprolactinemia has been proposed as a triggering factor for autoimmune diseases. The increased levels of prolactin could induce an abnormal immune response. Herein, we present a patient with hyperprolactinemia who developed polyautoimmunity. Patient's symptoms were associated with slightly raised levels of prolactin (20-40 ng/mL) and administration of dopaminergic agonists.
    Language English
    Publishing date 2018-11-09
    Publishing country England
    Document type Case Reports
    ZDB-ID 2740234-4
    ISSN 2050-0904
    ISSN 2050-0904
    DOI 10.1002/ccr3.1900
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top